Joshua M Eizen
Chief Operating Officer and Chief Legal Officer · 1 filing · Latest: Mar 19, 2026
AN2 Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|
Chief Operating Officer and Chief Legal Officer · 1 filing · Latest: Mar 19, 2026
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|